Accellent Inc (1342505) SEC Filing 10-K Annual report for the fiscal year ending Saturday, December 31, 2005

Accellent Inc

CIK: 1342505

Exhibit 99.1


Investor Contact: Stewart A. Fisher


Media Contact Information: Nanette Pietroforte



FischerHealth, Inc.

(610) 409-2225


(310) 577-7870, ext. 161


For Immediate Release


Accellent Inc. Announces Fourth Quarter 2005 Financial Results


Wilmington, MA. (March 8, 2006)

– Accellent Inc. (the “Company”), a wholly owned subsidiary of  Accellent Holdings Corp. (“Accellent”), announced strong results for the three and twelve months ended December 31, 2005, reflecting contributions from its acquisition of MedSource Technologies, Inc. (“MedSource”) on June 30, 2004  and continued organic growth.


KKR acquisition of Accellent


As previously disclosed, on November 22, 2005, affiliates of Kohlberg Kravis Roberts & Co. L.P. (“KKR”) and Bain Capital (“Bain”) completed the acquisition of the Company in a transaction valued at approximately $1.27 billion. As part of the transaction, members of Accellent management partnered with KKR and Bain by retaining an equity stake in Accellent. The acquisition resulted in several large expenses for merger-related costs, debt prepayment penalties, stock compensation, accelerated interest expense and purchase accounting for inventory. The Company’s results excluding these unusual items can be derived from the tables reconciling net income (loss) to EBITDA to adjusted EBITDA(1).


Recent Acquisitions


As previously announced, the Company completed two acquisitions in the later part of 2005 focused on the growing spine and knee replacement segments of the orthopaedic industry (“2005 acquisitions”). On September 12, 2005 the Company acquired substantially all of the assets of Campbell Engineering, Inc. (“Campbell”) and on October 6, 2005 the Company acquired Machining Technology Group, LLC (“MTG”). The 2005 acquisitions strengthen the Company’s ability to supply a full range of innovative design, quick-turn development, engineering services, component production, and device assembly to its orthopaedic customers. The results from the acquisitions are included in the Company’s historical results from the date of acquisition.


Historical Financial Results


Fourth Quarter Financial Results


Net sales for the fourth quarter of 2005 increased 12.3% to $120.9 million compared with $107.7 million in the corresponding period of 2004. The net loss for the fourth quarter of 2005 was $(116.7) million compared to net income in the corresponding period of 2004 of $0.8 million. The net loss for the fourth quarter of 2005 includes merger related costs of $47.9 million, debt prepayment penalties of $29.9 million, write-offs of deferred financing costs of $14.4 million, $2.4 million of bridge loan expenses, stock based compensation charges of $13.1 million, inventory step charges related to acquisitions of $10.8 million, in-process R&D write-offs of $8.0 million, and restructuring and other expenses of $0.6 million.


Adjusted EBITDA(1) for the fourth quarter of 2005 increased 30.2% to $26.2 million compared to $20.2 million in the corresponding period of 2004. Reconciliations of non-GAAP financial measures to GAAP financial measures are provided in the financial statements accompanying this press release.





The following information was filed by Accellent Inc on Wednesday, March 8, 2006 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-K Annual Report statement of earnings and operation as management may choose to highlight particular information in the press release.

View differences made from one year to another to evaluate Accellent Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Accellent Inc.


Assess how Accellent Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Accellent Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2006 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools

Material Contracts, Statements, Certifications & more

Accellent Inc provided additional information to their SEC Filing as exhibits

CIK: 1342505
Form Type: 10-K Annual Report
Accession Number: 0001104659-06-020541
Submitted to the SEC: Thu Mar 30 2006 1:39:54 PM EST
Accepted by the SEC: Thu Mar 30 2006
Period: Saturday, December 31, 2005
Industry: Surgical And Medical Instruments And Apparatus

External Resources:

Bookmark the Permalink: